Related Experiment Videos
A practice-based research network focused on comparative effectiveness research in type 2 diabetes management.
John E Anderson1, Andrew S Rhinehart, Timothy S Reid
1The Frist Clinic, Nashville, TN 37203, USA. john.anderson1@hcahealthcare.com
Postgraduate Medicine
|June 11, 2013
Summary
Diabetes FORWARD establishes a North American research platform for type 2 diabetes mellitus (T2DM) care. This real-world data network will improve understanding of individualized patient management and outcomes in primary care settings.
Area of Science:
- Endocrinology and Diabetes Care
- Health Services Research
- Comparative Effectiveness Research
Background:
- Type 2 diabetes mellitus (T2DM) management varies significantly in real-world clinical practice.
- Understanding patient management in primary care is crucial for improving health outcomes.
- Existing research often lacks data from diverse, typical patient populations.
Purpose of the Study:
- To establish a practice-based research network for T2DM in North America.
- To conduct comparative effectiveness research and inform healthcare decision-making.
- To gain insights into individualized patient management strategies in primary care.
Main Methods:
- Diabetes FORWARD (Foundation of Real-World Assessment and Research in Diabetes) is a longitudinal, noninterventional study.
- Anticipates enrollment of 10,000 patients with T2DM, stratified for primary care representation.
- Utilizes streamlined data collection via electronic medical records and patient surveys.
Main Results:
- Expected to yield real-world data on T2DM management variations across settings and clinicians.
- Will assess the impact of management on glycemic control, adherence, and clinical outcomes.
- Will track the effect of diabetes management on microvascular and cardiovascular complications at 6-month intervals.
Conclusions:
- Diabetes FORWARD is the first diabetes-focused, practice-based research network in the US and Canada.
- The platform will provide robust data reflecting typical T2DM clinical management in North America.
- Findings will enhance understanding of real-world diabetes care and support evidence-based decision-making.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...